The abstract is read at the publisher; the summary is JClub's.
Non-live vaccines are safe across all inborn errors of immunity subtypes, while live attenuated vaccines are contraindicated in many subtypes, with exceptions possible after individual assessment.
- Why it matters: Existing vaccination guidance is not tailored to IEI subtype and IUIS grouping, leaving clinicians without practical, risk-aligned recommendations for immune defects, vaccine types, and therapies.
- What they did: An ESID expert panel developed evidence-based, IUIS 2024–aligned guidelines using ≥75% agreement for contested points, incorporating immune defect, vaccine type, treatment regimen, and exposure risk.
- The result: Influenza and pneumococcal vaccines are strongly recommended for IEI patients, and the guidelines add subtype-specific recommendations for tick-borne encephalitis and SARS-CoV-2, plus treatment- and travel-focused advice.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.